Rapamycin Reverses Status Epilepticus-Induced Memory Deficits and Dendritic Damage

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Brewster, Amy L ^a   Lugo, Joaquin N ^a   Patil, Vinit V ^a   Lee, Wai L ^a   Qian, Yan ^a   Vanegas, Fabiola ^a   Anderson, Anne E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC NUCLEOTIDE GATED CHANNEL; GLUTAMATE DECARBOXYLASE 67; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MICROTUBULE ASSOCIATED PROTEIN 2; PILOCARPINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.2; POTASSIUM CHANNEL KV1.4; POTASSIUM CHANNEL KV4.2; RAPAMYCIN; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITE; DENDRITIC SPINE; EPILEPTIC STATE; GLIOSIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; MALE; MAZE TEST; MEMORY DISORDER; MICROGLIA; NERVE CELL; NERVE CELL LESION; NONHUMAN; RAT; RECOGNITION; SIGNAL TRANSDUCTION; SPATIAL LEARNING; SPATIAL MEMORY; TASK PERFORMANCE;

ANIMALS; DENDRITES; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; GLIOSIS; HIPPOCAMPUS; ION CHANNELS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICROGLIA; MULTIPROTEIN COMPLEXES; NEURONS; PHOSPHORYLATION; PILOCARPINE; RATS; RIBOSOMAL PROTEIN S6 KINASES; SIROLIMUS; STATUS EPILEPTICUS; TOR SERINE-THREONINE KINASES;

EID: 84874902329     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057808     Document Type: Article

References (70)

1. Holmes GL, (2004) Effects of early seizures on later behavior and epileptogenicity. Ment Retard Dev Disabil Res Rev 10: 101-105.
2. McKay BE, Persinger MA, (2004) Normal spatial and contextual learning for ketamine-treated rats in the pilocarpine epilepsy model. Pharmacol Biochem Behav 78: 111-119.
3. Chauviere L, Rafrafi N, Thinus-Blanc C, Bartolomei F, Esclapez M, et al. (2009) Early deficits in spatial memory and theta rhythm in experimental temporal lobe epilepsy. J Neurosci 29: 5402-5410.
4. Jensen FE, (2012) Epilepsy as a spectrum disorder: Implications from novel clinical and basic neuroscience. Epilepsia 52 (Suppl 1): 1-6.
5. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, et al. (2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50: 377-388.
6. Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, et al. (2008) Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 14: 843-848.
7. Zhou J, Blundell J, Ogawa S, Kwon CH, Zhang W, et al. (2009) Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 29: 1773-1783.
8. Buckmaster PS, Ingram EA, Wen X, (2009) Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy. J Neurosci 29: 8259-8269.
9. Zeng LH, Rensing NR, Wong M, (2009) The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 29: 6964-6972.
10. Costa-Mattioli M, Sossin WS, Klann E, Sonenberg N, (2009) Translational control of long-lasting synaptic plasticity and memory. Neuron 61: 10-26.
11. Richter JD, Klann E, (2009) Making synaptic plasticity and memory last: mechanisms of translational regulation. Genes Dev 23: 1-11.
12. Raab-Graham KF, Haddick PC, Jan YN, Jan LY, (2006) Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites. Science 314: 144-148.
13. Lee HY, Ge WP, Huang W, He Y, Wang GX, et al. (2011) Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein. Neuron 72: 630-642.
14. Gong R, Park CS, Abbassi NR, Tang SJ, (2006) Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem 281: 18802-18815.
15. Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, Sheng M, (2005) Control of dendritic arborization by the phosphoinositide-3′-kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 25: 11300-11312.
16. Kumar V, Zhang MX, Swank MW, Kunz J, Wu GY, (2005) Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 25: 11288-11299.
17. Dello Russo C, Lisi L, Tringali G, Navarra P, (2009) Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. Biochem Pharmacol 78: 1242-1251.
18. Lu DY, Liou HC, Tang CH, Fu WM, (2006) Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Biochem Pharmacol 72: 992-1000.
19. Hay N, Sonenberg N, (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
20. Swann JW, Al-Noori S, Jiang M, Lee CL, (2000) Spine loss and other dendritic abnormalities in epilepsy. Hippocampus 10: 617-625.
21. Zeng LH, Xu L, Rensing NR, Sinatra PM, Rothman SM, et al. (2007) Kainate seizures cause acute dendritic injury and actin depolymerization in vivo. J Neurosci 27: 11604-11613.
22. Jalava NS, Lopez-Picon FR, Kukko-Lukjanov TK, Holopainen IE, (2007) Changes in microtubule-associated protein-2 (MAP2) expression during development and after status epilepticus in the immature rat hippocampus. Int J Dev Neurosci 25: 121-131.
23. Nishimura M, Gu X, Swann JW, (2011) Seizures in early life suppress hippocampal dendrite growth while impairing spatial learning. Neurobiol Dis 44: 205-214.
24. Bernard C, Anderson A, Becker A, Poolos NP, Beck H, et al. (2004) Acquired dendritic channelopathy in temporal lobe epilepsy. Science 305: 532-535.
25. Jung S, Jones TD, Lugo JN Jr, Sheerin AH, Miller JW, et al. (2007) Progressive dendritic HCN channelopathy during epileptogenesis in the rat pilocarpine model of epilepsy. J Neurosci 27: 13012-13021.
26. Monaghan MM, Menegola M, Vacher H, Rhodes KJ, Trimmer JS, (2008) Altered expression and localization of hippocampal A-type potassium channel subunits in the pilocarpine-induced model of temporal lobe epilepsy. Neuroscience 156: 550-562.
27. Racine RJ, (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281-294.
28. Sunnen CN, Brewster AL, Lugo JN, Vanegas F, Turcios E, et al. (2011) Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice. Epilepsia 52: 2065-2075.
29. Lugo JN, Brewster AL, Spencer CM, Anderson AE, (2012) Kv4.2 knockout mice have hippocampal-dependent learning and memory deficits. Learn Mem 19: 182-189.
30. Fenoglio KA, Brunson KL, Avishai-Eliner S, Stone BA, Kapadia BJ, et al. (2005) Enduring, handling-evoked enhancement of hippocampal memory function and glucocorticoid receptor expression involves activation of the corticotropin-releasing factor type 1 receptor. Endocrinology 146: 4090-4096.
31. Lugo JN, Barnwell LF, Ren Y, Lee WL, Johnston LD, et al. (2008) Altered phosphorylation and localization of the A-type channel, Kv4.2 in status epilepticus. J Neurochem 106: 1929-1940.
32. Ljungberg MC, Sunnen CN, Lugo JN, Anderson AE, D'Arcangelo G, (2009) Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech 2: 389-398.
33. Brewster AL, Chen Y, Bender RA, Yeh A, Shigemoto R, et al. (2007) Quantitative analysis and subcellular distribution of mRNA and protein expression of the hyperpolarization-activated cyclic nucleotide-gated channels throughout development in rat hippocampus. Cereb Cortex 17: 702-712.
34. Wang HF, Shih YT, Chen CY, Chao HW, Lee MJ, et al. (2011) Valosin-containing protein and neurofibromin interact to regulate dendritic spine density. J Clin Invest 121: 4820-4837.
35. Goorden SM, van Woerden GM, van der Weerd L, Cheadle JP, Elgersma Y, (2007) Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures. Ann Neurol 62: 648-655.
36. Zeng LH, Xu L, Gutmann DH, Wong M, (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63: 444-453.
37. Huang X, Zhang H, Yang J, Wu J, McMahon J, et al. (2010) Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy. Neurobiol Dis 40: 193-199.
38. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, et al. (2007) RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem 282: 14056-14064.
39. Pende M, Um SH, Mieulet V, Sticker M, Goss VL, et al. (2004) S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 24: 3112-3124.
40. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, et al. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22: 159-168.
41. Sha LZ, Xing XL, Zhang D, Yao Y, Dou WC, et al. (2012) Mapping the Spatio-Temporal Pattern of the Mammalian Target of Rapamycin (mTOR) Activation in Temporal Lobe Epilepsy. PLoS One 7: e39152.
42. Shapiro LA, Wang L, Ribak CE, (2008) Rapid astrocyte and microglial activation following pilocarpine-induced seizures in rats. Epilepsia 49: 33-41.
43. Vezzani A, French J, Bartfai T, Baram TZ, (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7: 31-40.
44. Kettenmann H, (2006) Triggering the brain's pathology sensor. Nat Neurosci 9: 1463-1464.
45. Nishimura M, Owens J, Swann JW, (2008) Effects of chronic network hyperexcitability on the growth of hippocampal dendrites. Neurobiol Dis 29: 267-277.
46. Oliveira MS, Skinner F, Arshadmansab MF, Garcia I, Mello CF, et al. (2010) Altered expression and function of small-conductance (SK) Ca(2+)-activated K+ channels in pilocarpine-treated epileptic rats. Brain Res 1348: 187-199.
47. Nolan MF, Malleret G, Dudman JT, Buhl DL, Santoro B, et al. (2004) A behavioral role for dendritic integration: HCN1 channels constrain spatial memory and plasticity at inputs to distal dendrites of CA1 pyramidal neurons. Cell 119: 719-732.
48. Hammond RS, Bond CT, Strassmaier T, Ngo-Anh TJ, Adelman JP, et al. (2006) Small-conductance Ca2+-activated K+ channel type 2 (SK2) modulates hippocampal learning, memory, and synaptic plasticity. J Neurosci 26: 1844-1853.
49. Chen X, Yuan LL, Zhao C, Birnbaum SG, Frick A, et al. (2006) Deletion of Kv4.2 gene eliminates dendritic A-type K+ current and enhances induction of long-term potentiation in hippocampal CA1 pyramidal neurons. J Neurosci 26: 12143-12151.
50. Talos DM, Sun H, Zhou X, Fitzgerald EC, Jackson MC, et al. (2012) The Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) Pathway. PLoS One 7: e35885.
51. Stoica L, Zhu PJ, Huang W, Zhou H, Kozma SC, et al. (2011) Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc Natl Acad Sci 108: 3791-3796.
52. Raffo E, Coppola A, Ono T, Briggs SW, Galanopoulou AS, (2011) A pulse rapamycin therapy for infantile spasms and associated cognitive decline. Neurobiol Dis 43: 322-329.
53. Huang X, McMahon J, Huang Y, (2012) Rapamycin attenuates aggressive behavior in a rat model of pilocarpine-induced epilepsy. Neuroscience 215: 90-97.
54. Dash PK, Orsi SA, Moore AN, (2006) Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex-Mammalian target of rapamycin pathway. J Neurosci 26: 8048-8056.
55. Parsons RG, Gafford GM, Helmstetter FJ, (2006) Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons. J Neurosci 26: 12977-12983.
56. Chachua T, Poon KL, Yum MS, Nesheiwat L, Desantis K, et al. (2012) Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats. Epilepsia 53: 2015-2025.
57. Hartman AL, Santos P, Dolce A, Hardwick JM, (2012) The mTOR inhibitor rapamycin has limited acute anticonvulsant effects in mice. PLoS One 7: e45156.
58. Buckmaster PS, Lew FH, (2011) Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy. J Neurosci 31: 2337-2347.
59. Staley KJ, Dudek FE, (2006) Interictal spikes and epileptogenesis. Epilepsy Curr 6: 199-202.
60. Erlich S, Alexandrovich A, Shohami E, Pinkas-Kramarski R, (2007) Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 26: 86-93.
61. Hailer NP, (2008) Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 84: 211-233.
62. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, et al. (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333: 1456-1458.
63. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J, (2009) Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29: 3974-3980.
64. Milatovic D, Zaja-Milatovic S, Montine KS, Horner PJ, Montine TJ, (2003) Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J Neurochem 87: 1518-1526.
65. Tanaka S, Ide M, Shibutani T, Ohtaki H, Numazawa S, et al. (2006) Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J Neurosci Res 83: 557-566.
66. Muller CJ, Bankstahl M, Groticke I, Loscher W, (2009) Pilocarpine vs. lithium-pilocarpine for induction of status epilepticus in mice: development of spontaneous seizures, behavioral alterations and neuronal damage. Eur J Pharmacol 619: 15-24.
67. Harada A, Teng J, Takei Y, Oguchi K, Hirokawa N, (2002) MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. J Cell Biol 158: 541-549.
68. Dehmelt L, Halpain S, (2005) The MAP2/Tau family of microtubule-associated proteins. Genome Biol 6: 204.
69. Maletic-Savatic M, Lenn NJ, Trimmer JS, (1995) Differential spatiotemporal expression of K+ channel polypeptides in rat hippocampal neurons developing in situ and in vitro. J Neurosci 15: 3840-3851.
70. Lang UE, Heger J, Willbring M, Domula M, Matschke K, et al. (2009) Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement. Transplant Proc 41: 4285-4288.